Document is current
Any future updates will be listed below
-
Authors
Innocenti, Gabriel
Andreu-Sánchez, Sergio
Hörstke, Nicolai V.
Elabd, Hesham
Barozzi, Iros
Franke, Andre
Manczinger, Máté
Vogl, Thomas https://orcid.org/0000-0002-3892-1740
-
Funding
Funding for this research was provided by:
FP7 Ideas: European Research Council (101075733)
HORIZON EUROPE Health (101136582, 101136582)
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 9 May 2025
First Online: 2 June 2025
Declarations
:
: For Lifelines cohort, approval from institutional ethics review is available under reference number M12.113965. For 1000IBD, ethical approval has been granted by the Institutional Review Board of “Medisch Ethische Toetsingscommissie” (METc) from the UMCG under the registration number 2008/338. The study has been conducted in accordance with the principles of the Declaration of Helsinki (2013). Patients provided written informed consent for their participation in the study.
: See previous section.
: The authors declare that they have no competing interests.
